Depression and Anxiety Affect Women with MS During Pregnancy and the First Year After Childbirth
National Multiple Sclerosis Society News
by
5d ago
A new study of nearly 900,000 Canadian women shows that depression, anxiety, and other mental health issues affected women with MS more than those with other or no disorders – both during pregnancy and the year after childbirth ..read more
Visit website
National Multiple Sclerosis Society Awards Dr. Mikael Simons with Barancik Prize for Innovation in MS Research
National Multiple Sclerosis Society News
by
5d ago
Dr. Simons is being recognized for his pioneering work on myelin and glial cells ..read more
Visit website
Study Shows an Experimental Therapy May Help Improve Myelin Repair and Nerve Cell Function
National Multiple Sclerosis Society News
by
5d ago
With funding support from the National Multiple Sclerosis Society, researchers at the University of Colorado Anschutz Medical Campus showed that a new experimental therapy can support myelin repair and improve brain function associated with vision ..read more
Visit website
New Study Suggests that Medication Usage for Nerve Pain is Increased Before Onset and Diagnosis of MS
National Multiple Sclerosis Society News
by
2w ago
Research funded in part by the National MS Society showed that in the five years leading up to MS onset, people with MS filled more prescriptions for medicines used to treat nerve pain compared to people without MS, suggesting pain as a symptom of the MS prodrome ..read more
Visit website
New Program: Mentoring College Students in MS Research
National Multiple Sclerosis Society News
by
2w ago
The National MS Society is launching an Undergraduate Summer Research Program, designed to provide college students with hands-on experience in conducting MS-related research ..read more
Visit website
Tolebrutinib Granted “Breakthrough Therapy” Designation by FDA to Speed its Potential Approval for Non-relapsing Secondary Progressive MS
National Multiple Sclerosis Society News
by
2w ago
Sanofi, Inc. has announced that tolebrutinib — an experimental, oral BTK-inhibitor — has been designated by the U.S. Food and Drug Administration as a “Breakthrough Therapy” for treatment of non-relapsing secondary progressive MS ..read more
Visit website
Department of Transportation Enacts Protections for Airline Passengers with Disabilities
National Multiple Sclerosis Society News
by
2w ago
In December, the Department of Transportation (DOT) adopted rules aimed at protecting the safety of airline passengers with disabilities ..read more
Visit website
Congress Passes Short-Term Spending Bill with Telehealth Expansion and MS Research Funding
National Multiple Sclerosis Society News
by
2w ago
In December, the Department of Transportation (DOT) adopted rules aimed at protecting the safety of airline passengers with disabilities ..read more
Visit website
New Study Indicates MS May Worsen During Menopause
National Multiple Sclerosis Society News
by
2w ago
Researchers at the University of California – San Francisco found that menopause onset is associated with increased functional decline and brain cell injury in MS ..read more
Visit website
Large Study of Exposure to DMTs During Pregnancy Finds Some Associations with Low Birth Weight with No Other Notable Adverse Outcomes
National Multiple Sclerosis Society News
by
2w ago
Today, the U.S. Federal Trade Commission (FTC) published “Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers ..read more
Visit website

Follow National Multiple Sclerosis Society News on FeedSpot

Continue with Google
Continue with Apple
OR